“This adds to the growing evidence that inflammation plays a role in patients with schizophrenia and again suggests that targeting inflammation may be a viable therapeutic target, at least for cognitive impairment, which is a … Share this:Click to share on Pinterest (Opens in new window)Click to share on Pocket (Opens in new window)Click to share on WhatsApp (Opens in new window)Click to share on Facebook (Opens in new window)Click to share on Tumblr (Opens in new window)Click to share on LinkedIn (Opens in new window)Click to share on Telegram (Opens in new window)Click to share on Twitter (Opens in new window)Click to share on Reddit (Opens in new window)Click to print (Opens in new window)Click to email a link to a friend (Opens in new window)Like this:Like Loading...